
LENSAR Inc (LNSR) Stock Forecast & Price Target
LENSAR Inc (LNSR) Analyst Ratings
Bulls say
LENSAR is a commercial-stage medical device company that develops and markets an advanced femtosecond laser system for cataract treatment and management. With its proprietary technologies and focus on visual outcomes, efficiency, and precision, LENSAR is well-positioned for growth in the market. The company has a strong product portfolio and continues to see increasing adoption and utilization of its systems, which supports its recurring revenue stream. Despite facing challenges with the failed acquisition by Alcon (ALC), LENSAR has remained resilient and is poised for further growth with a diverse customer base and a growing market for femtosecond laser systems.
Bears say
LENSAR is a small-cap technology play on the fast-growing cataract surgery market, with a strong foothold in the laser segment and a unique offering in its ALLY system. Despite a steady cadence of revenue growth and above-peer CAGR, the company is currently trading at a significant discount to its ophthalmic peers, suggesting potential downside risks to our estimates and price target are likely due to slower uptake of ALLY, lower growth of FLACS, and higher operating expenditures.
This aggregate rating is based on analysts' research of LENSAR Inc and is not a guaranteed prediction by Public.com or investment advice.
LENSAR Inc (LNSR) Analyst Forecast & Price Prediction
Start investing in LENSAR Inc (LNSR)
Order type
Buy in
Order amount
Est. shares
0 shares